Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor

BMC Veterinary Research

Volumn 8, Issue , 2012, Pages

  Chiang, Hsin Chien ^a   Wang, Yu Shan ^a,b   Chou, Chung Hsi ^a   Liao, Albert Taiching ^a   Chu, Rea Min ^a   Lin, Chen Si ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

CTVT; CXCL7; CXCR2; IL 6; TGF

Indexed keywords

ALPHA CHEMOKINE; COMPLEMENTARY DNA; INTERLEUKIN 6; MESSENGER RNA;

ANIMAL; ANIMAL VENEREAL TUMOR; ARTICLE; CELL CULTURE; DOG; DOG DISEASE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; CHEMOKINES, CXC; DNA, COMPLEMENTARY; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERLEUKIN-6; MALE; RNA, MESSENGER; VENEREAL TUMORS, VETERINARY;

MLCS; MLOWN;

EID: 84868544948     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-8-216     Document Type: Article

References (34)

1. Murgia C, Pritchard J, Kim SY, Fassati A, Weiss RA. Clonal Origin and Evolution of a Transmissible Cancer. Cell 2006, 126:477-487. 10.1016/j.cell.2006.05.051, 2593932, 16901782.
2. Chu RM, Lin CY, Liu CC, Yang SY, Hsiao YW, Hung SW, Pao HN, Liao KW. Proliferation characteristics of canine transmissible venereal tumor. Anticancer Res 2001, 21(6A):4017-4024.
3. Cohen D. The canine transmissible venereal tumor: a unique result of tumor progression. Adv Cancer Res 1985, 43:75-112.
4. Hsiao YW, Liao KW, Hung SW, Chu RM. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells. Vet Immunol Immunopathol 2002, 87(1-2):19-27.
5. Hsiao YW, Liao KW, Hung SW, Chu RM. Tumor-Infiltrating Lymphocyte Secretion of IL-6 Antagonizes Tumor-Derived TGF-beta1 and Restores the Lymphokine-Activated Killing Activity. J Immunol 2004, 172(3):1508-1514.
6. Baggiolini M. Activation and recruitment of neutrophil leukocytes. Clin Exp Immunol 1995, 101(Suppl 1):5-6. 1553551, 7606860.
7. Feniger-Barish R, Ran M, Zaslaver A, Ben-Baruch A. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Cytokine 1999, 11(12):996-1009. 10.1006/cyto.1999.0510, 10623425.
8. Ludwig A, Petersen F, Zahn S, Gotze O, Schroder JM, Flad HD, Brandt E. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 1997, 90(11):4588-4597.
9. Walz A, Baggiolini M. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. Biochem Biophys Res Commun 1989, 159(3):969-975. 10.1016/0006-291X(89)92203-1, 2522778.
10. Detmers PA, Powell DE, Walz A, Clark-Lewis I, Baggiolini M, Cohn ZA. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 1991, 147(12):4211-4217.
11. Bieche I, Chavey C, Andrieu C, Busson M, Vacher S, Le Corre L, Guinebretiere JM, Burlinchon S, Lidereau R, Lazennec G. CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer 2007, 14(4):1039-1052. 10.1677/erc.1.01301, 18045955.
12. Park JY, Park KH, Bang S, Kim MH, Lee JE, Gang J, Koh SS, Song SY. CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol 2007, 133(11):835-840. 10.1007/s00432-007-0225-x, 17479287.
13. Begley LA, Kasina S, Mehra R, Adsule S, Admon AJ, Lonigro RJ, Chinnaiyan AM, Macoska JA. CXCL5 promotes prostate cancer progression. Neoplasia 2008, 10(3):244-254. 2262133, 18320069.
14. O'Hayre M, Salanga CL, Handel TM, Allen SJ. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 2008, 409(3):635-649. 10.1042/BJ20071493, 18177271.
15. Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim Biophys Acta 2007, 1768(4):952-963. 10.1016/j.bbamem.2006.11.002, 1952230, 17169327.
16. Wang YS, Liao KW, Chen MF, Huang YC, Chu RM, Chi KH. Canine CXCL7 and its functional expression in dendritic cells undergoing maturation. Vet Immunol Immunopathol 2010, 135(1-2):128-136.
17. Liu CC, Wang YS, Lin CY, Chuang TF, Liao KW, Chi KH, Chen MF, Chiang HC, Chu RM. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor. Cancer Immunol Immunother 2008, 57(4):479-491. 10.1007/s00262-007-0386-0, 17710396.
18. Hsiao YW, Liao KW, Chung TF, Liu CH, Hsu CD, Chu RM. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression. Cancer Immunol Immunother 2008, 57(7):1091-1104. 10.1007/s00262-007-0446-5, 18259750.
19. Liao KW, Hung SW, Hsiao YW, Bennett M, Chu RM. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells. Vet Immunol Immunopathol 2003, 92(3-4):149-162.
20. Kruidenier L, MacDonald TT, Collins JE, Pender SLF, Sanderson IR. Myofibroblast Matrix Metalloproteinases Activate the Neutrophil Chemoattractant CXCL7 From Intestinal Epithelial Cells. Gastroenterology 2006, 130(1):127-136. 10.1053/j.gastro.2005.09.032, 16401476.
21. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996, 97(12):2792-2802. 10.1172/JCI118734, 507372, 8675690.
22. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY, Burdick MD, Glass MC, Iannettoni MD, Strieter RM. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 1998, 102(3):465-472. 10.1172/JCI3145, 508906, 9691082.
23. Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L, Inferrera C. Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 2002, 15(8):831-837. 10.1097/01.MP.0000020391.98998.6B, 12181268.
24. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001, 97(2):339-345. 10.1182/blood.V97.2.339, 11154206.
25. Welch DR, Schissel DJ, Howrey RP, Aeed PA. Tumor-elicited polymorphonuclear cells, in contrast to " normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci U S A 1989, 86(15):5859-5863. 10.1073/pnas.86.15.5859, 297730, 2762301.
26. McLoughlin RM, Hurst SM, Nowell MA, Harris DA, Horiuchi S, Morgan LW, Wilkinson TS, Yamamoto N, Topley N, Jones SA. Differential Regulation of Neutrophil-Activating Chemokines by IL-6 and Its Soluble Receptor Isoforms. J Immunol 2004, 172(9):5676-5683.
27. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990, 11(12):443-449.
28. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 1990, 4(11):2860-2867.
29. Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL. Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion. J Immunol 1993, 150(11):4844-4855.
30. Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, Rose-John S, Fuller GM, Topley N, Jones SA. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001, 14(6):705-714. 10.1016/S1074-7613(01)00151-0, 11420041.
31. Maxwell PJ, Gallagher R, Seaton A, Wilson C, Scullin P, Pettigrew J, Stratford IJ, Williams KJ, Johnston PG, Waugh DJJ. HIF-1 and NF-[kappa]B-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene 2007, 26(52):7333-7345. 10.1038/sj.onc.1210536, 17533374.
32. Loetscher P, Seitz M, Baggiolini M, Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996, 184(2):569-577. 10.1084/jem.184.2.569, 2192704, 8760810.
33. Wang YS, Chi KH, Chu RM. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation. Vet Immunol Immunopathol 2007, 118(3-4):186-198.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.